Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

× No keyword cloud information.

8 in total

1. Survival outcome differences based on treatments used and knowledge of the primary tumour site for patients with cancer of unknown and known primary in Ontario.

Authors: C S Kim; M B Hannouf; S Sarma; G B Rodrigues; P K Rogan; S M Mahmud; E Winquist; M Brackstone; G S Zaric
Journal: Curr Oncol Date: 2018-10-31 Impact factor: 3.677

Review 2. Carcinomas of an unknown primary origin--diagnosis and treatment.

Authors: Christophe Massard; Yohann Loriot; Karim Fizazi
Journal: Nat Rev Clin Oncol Date: 2011-11-01 Impact factor: 66.675

Review 3. [The role of pathology in the diagnostics of CUP syndrome].

Authors: A Stenzinger; M Kriegsmann; W Weichert
Journal: Radiologe Date: 2014-02 Impact factor: 0.635

4. Clinical utility of gene-expression profiling for tumor-site origin in patients with metastatic or poorly differentiated cancer: impact on diagnosis, treatment, and survival.

Authors: Scott J Nystrom; John C Hornberger; Gauri R Varadhachary; Richard J Hornberger; Hialy R Gutierrez; David W Henner; Shawn H Becker; Mahul B Amin; Michael G Walker
Journal: Oncotarget Date: 2012-06

8. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.

Authors: Matias Riihimäki; Hauke Thomsen; Akseli Hemminki; Kristina Sundquist; Kari Hemminki
Journal: BMC Cancer Date: 2013-01-28 Impact factor: 4.430

8 in total

Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

1. Survival outcome differences based on treatments used and knowledge of the primary tumour site for patients with cancer of unknown and known primary in Ontario.

Review 2. Carcinomas of an unknown primary origin--diagnosis and treatment.

Review 3. [The role of pathology in the diagnostics of CUP syndrome].

4. Clinical utility of gene-expression profiling for tumor-site origin in patients with metastatic or poorly differentiated cancer: impact on diagnosis, treatment, and survival.

5. Immunohistochemical profile for unknown primary adenocarcinoma.

6. Location of metastases in cancer of unknown primary are not random and signal familial clustering.

7. Somatic substitution signature as an innovative tool in lung cancer diagnosis.

8. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.